PRTA - Prothena Corporation plc
IEX Last Trade
22.29
0.730 3.275%
Share volume: 300,305
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$21.56
0.73
3.39%
Summary score
11%
Profitability
0%
Dept financing
6%
Liquidity
75%
Performance
8%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-6.38%
Return on assets
-4.9%
Return on sales
-16661.6%
Return on invested capital
-2157.59%
Total debt ratio
26.94%
Debt ratio change over timeo
-1.05%
Current Ratio
13.73%
Quick Ratio
13.73%
Cash Position Ratio
13.43%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-8.06%
Return on assets
-8.05%
Return on sales
-47386.28%
Return on invested capital
-7965.12%
Total debt ratio
18.85%
Debt ratio change over timeo
-0.98%
Current Ratio
11.68%
Quick Ratio
11.68%
Cash Position Ratio
11.32%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-14.38%
Return on assets
-13.08%
Return on sales
-163056%
Return on invested capital
-513.79%
Total debt ratio
19.38%
Debt ratio change over time
-1%
Current Ratio
13.08%
Quick Ratio
13.08%
Cash Position Ratio
12.63%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-100.34%
Return on assets
-100.47%
Return on sales
1079.43%
Return on invested capital
385.69%
Total debt ratio
-105.13%
Debt ratio change over time
-1.05%
Current Ratio
-2.91%
Quick Ratio
-2.91%
Cash Position Ratio
-2.89%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PRTA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -6.38% | 13.79% | 34.47% | 7.43% |
| Return on assets | -4.9% | 2.76% | 3.15% | 5.62% |
| Return on sales | -16661.6% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -2157.59% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 26.94% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.05% | 308.97% | -6.99% | 1.18% |
| Dept financing | 7% | 50% | 25% | 7% |
| Current Ratio | 11.68% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 11.68% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 11.32% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 4% | 8% | 19% |
| Short-term ratios | PRTA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.06% | 13.77% | 13.25% | 3.8% |
| Return on assets | -8.05% | 2.43% | 1.89% | 3.09% |
| Return on sales | -47386.28% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -7965.12% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 18.85% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.98% | 46.38% | -72.08% | 1.51% |
| Dept financing | 5% | 50% | 25% | 7% |
| Current Ratio | 11.68% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 11.68% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 11.32% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 4% | 11% | 28% |